Gland Pharma Appoints Ajay Sahni as CEO of Gland Pharma International
Gland Pharma Ltd 路 Change in Management 路 30 Oct 2026, 10:05 pm
Gland Pharma Appoints Ajay Sahni as CEO of Gland Pharma International Gland Pharma Limited has appointed Ajay Sahni as Chief Executive Officer of its wholly owned subsidiary, Gland Pharma International Pte. Ltd. (Gland Singapore), effective 2nd Nov'26. Sahni will oversee the Cenexi business, a wholly owned step-down subsidiary, and report directly to the CEO of Gland Pharma Limited. Bringing over 36 years of experience across FMCG and pharmaceuticals, Sahni has previously held senior leadership and managing director roles at Sanofi, Ferring Pharmaceuticals, Pinewood Healthcare, and Wockhardt subsidiaries across Europe, the US, and Asia.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
